-+ 0.00%
-+ 0.00%
-+ 0.00%

SUMMIT THERAPUETICS FALL 9.7% TO NEAR THREE-MONTH LOW AFTER FDA DECLINES APPROVAL OF CO'S LUNG CANCER DRUG

Reuters·11/16/2026 14:35:08